Number of the records: 1
Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application
- 1.
SYSNO ASEP 0356672 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application Author(s) Skalníková, Helena (UZFG-Y) RID, ORCID
Martinková, Jiřina (UZFG-Y)
Hrabáková, Rita (UZFG-Y) RID, ORCID
Halada, Petr (MBU-M) RID, ORCID
Dziechciarková, M. (CZ)
Hajdúch, M. (CZ)
Gadher, S. J. (CH)
Hammar, A. (SE)
Enetoft, D. (SE)
Ekefjard, A. (SE)
Forsstrom-Olsson, O. (SE)
Kovářová, Hana (UZFG-Y) RID, ORCIDSource Title Journal of Proteome Research. - : American Chemical Society - ISSN 1535-3893
Roč. 10, č. 2 (2011), s. 404-415Number of pages 12 s. Language eng - English Country US - United States Keywords cancer ; anti-cancer drugs ; drug resistance Subject RIV CE - Biochemistry R&D Projects LC07017 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) GA301/08/1649 GA ČR - Czech Science Foundation (CSF) CEZ AV0Z50450515 - UZFG-Y (2005-2011) AV0Z50200510 - MBU-M (2005-2011) UT WOS 000286868500004 DOI 10.1021/pr100468w Annotation Resistance to anti-cancer drugs is a well recognized problem and very often it is responsible for failure of the cancer treatment. In this study, the proteome alterations associated with the development of acquired resistance to cyclin-depedent kinases inhibitor bohemine, a promising anti-cancer drug, were analyzed with the primary aim of identifying potential targets of resistance within the cell that could pave a way to selective elimination of specific resistant cell types. A model of parental susceptible CEM T-lymphoblastic leukemia cells and its resistant counterpart CEM-BOH was used and advanced 2-D liquid chromatography was applied to fractionate cellular proteins. Differentially expressed identified proteins were further verified using immunoblotting and immunohistochemistry. Our study has revealed that Rho GDP-dissociation inhibitor 2, Y-box binding protein 1, and the HSP70/90 organizing protein have a critical role to play in resistance to cyclin-depedent kinases inhibitor. The results indicated not only that quantitative protein changes play an important role in drug-resistance, but also that there are various other parameters such as truncation, post-translational modification(s), and subcellular localization of selected proteins. Furthermore, these proteins were validated for their roles in drug resistance using different cell lines resistant to diverse representatives of anti-cancer drugs such as vincristine and daunorubicin Workplace Institute of Animal Physiology and Genetics Contact Jana Zásmětová, knihovna@iapg.cas.cz, Tel.: 315 639 554 Year of Publishing 2011
Number of the records: 1